Wei Li-Na, Law Ping-Yee, Loh Horace H
Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Front Biosci. 2004 May 1;9:1665-79. doi: 10.2741/1362.
Three types of opioid receptors exist in the animals, each is encoded by a single gene, i.e., the mu opioid receptor gene, the delta opioid receptor gene, and the kappa opioid receptor gene. However, each opioid receptor gene produces multiple mRNA variants as a result of alternative promoter usages, splicing and/or polyadenylation. As such, a large reservoir of regulatory events has evolved for the control of the production of mRNA variants or differentially modified proteins from each opioid receptor gene. This review focuses on post-transcriptional events for the regulation of opioid receptor expression or activities, including alternative splicing, mRNA stability, translation, RNA polyadenylation, RNA transport, and covalent modification of the receptors. Variation at the mRNA level contributes, primarily, to the control of spatial and temporal expression of these receptors in different parts of neurons; whereas modification at the receptors is the key for controlling the duration and amplitude of signals generated from these receptors.
动物体内存在三种阿片受体,每种受体由单个基因编码,即μ阿片受体基因、δ阿片受体基因和κ阿片受体基因。然而,由于启动子使用方式、剪接和/或聚腺苷酸化的差异,每个阿片受体基因都会产生多种mRNA变体。因此,为了控制每个阿片受体基因的mRNA变体或差异修饰蛋白的产生,已经进化出大量的调控机制。本综述聚焦于转录后事件对阿片受体表达或活性的调控,包括可变剪接、mRNA稳定性、翻译、RNA聚腺苷酸化、RNA转运以及受体的共价修饰。mRNA水平的变化主要有助于控制这些受体在神经元不同部位的时空表达;而受体的修饰则是控制这些受体产生信号的持续时间和幅度的关键。